[Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
作者信息
März Winfried
出版信息
MMW Fortschr Med. 2005 Apr 7;147(14):14.
PMID:15887675
Abstract
摘要
相似文献
1
[Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
MMW Fortschr Med. 2005 Apr 7;147(14):14.
2
[Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
MMW Fortschr Med. 2008 Jun 19;150(25):41-3.
3
What is the most effective strategy for managing diabetic dyslipidaemia?
Atheroscler Suppl. 2005 Sep;6(3):21-7. doi: 10.1016/j.atherosclerosissup.2005.06.005.
4
Choice of lipid-regulating drugs.
Med Lett Drugs Ther. 2001 May 28;43(1105):43-8.
5
[Dyslipidemia in diabetes mellitus].
Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):769-74.
6
Dyslipidaemia in diabetic patients: time for a rethink.
Diabetes Obes Metab. 2007 Sep;9(5):609-16. doi: 10.1111/j.1463-1326.2006.00642.x.
7
Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Am J Cardiol. 2008 Dec 22;102(12A):41L-47L. doi: 10.1016/j.amjcard.2008.09.074.
8
Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?
Am J Cardiol. 2005 Nov 7;96(9A):20K-27K; discussion 34K-35K. doi: 10.1016/j.amjcard.2005.08.004. Epub 2005 Sep 21.
9
Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1172-8. doi: 10.1161/ATVBAHA.107.160739. Epub 2008 Mar 20.
10
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003.
Zotero 插件